Skip navigation

DAY ONE — WEDNESDAY, OCTOBER 11, 2017

7:30

Registration and Continental Breakfast

8:30

Chairman’s Welcome and Opening Remarks

Michael O’Connor
former Global Head, Compliance Operations
Alexion Pharmaceuticals

Identify an Effective Strategy for
Managing HCP Engagement

8:45

Establish a Comprehensive and Regulatory Framework to Successfully Manage All HCP Interactions

Richard Eschle
Executive Director, Corporate Ethics and Compliance
Eisai

9:30

Keys to Develop a Comprehensive and Upstream Approach to Compliance

Michaeline Daboul
President & CEO
MediSpend

10:15

Networking and Refreshment Break

10:45

THINK TANK Benchmark on How HCP Engagement Brings Value to an Organization

This session allows for open discussion within a roundtable format with the speaker facilitating collaboration with the audience.

Gina Barbarotto, MS, MBA
Director, Patient & Professional Relations
Purdue Pharma, L.P.

11:45

A Five Year Plan —
Building a Compliant Ecosystem Using Technology and Services

Shelley Harris
Director, Marketing Operations
Alkermes

Susan M. Hill
Senior Vice President, Global Products & Solutions
AHM

Martin L. Magazzolo
Senior Vice President, Global Sales & Marketing
AHM

12:30

Networking Luncheon

1:45

Maximizing the Effectiveness of Healthcare Provider Interactions

Kobi Gershoni
Co-Founder & Chief Research Officer
Signals Analytics

2:30

Best Practices for Open Payments Reporting of HCP Spend

Gus Papandrikos
Senior Director, Compliance
Daiichi Sankyo

3:15

Networking and Refreshment Break

3:45

Best Practices for Managing HCP Customer Expectations

Josh Yoder, PhD
Medical Science Liaison
Vertex Pharmaceuticals

Scott McConnell, PharmD
Senior Director, Medical Affairs
Alkermes, Inc.

4:30

THINK TANK Share Ideas for Compliant HCP Engagement

This session allows for open discussion within a roundtable format with the speaker facilitating collaboration with the audience.

Michael O’Connor
former Global Head, Compliance Operations
Alexion Pharmaceuticals

5:15

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO — THURSDAY, OCTOBER 12, 2017

7:45

Continental Breakfast

8:15

Chairman’s Review of Day One

Michael O’Connor
former Global Head, Compliance Operations
Alexion Pharmaceuticals

Capitalize on an External Communication Strategy for Efficient Management with HCPs

8:30

Assess Communication with HCPs on Speaker Programs and Ensure Correct Messaging

Howard Dorfman
Founder
H.L. Dorfman Pharmaceutical Consulting, LLC

9:15

PANEL Overcome Challenges in Contract Management to Streamline
HCP Operations

MODERATOR:

Gus Papandrikos
Senior Director, Compliance
Daiichi Sankyo

PANELISTS:

Sheea Sybblis
Counsel, US and Worldwide Regulatory
Bristol-Myers Squibb

Howard Dorfman
Founder
H.L. Dorfman Pharmaceutical Consulting, LLC

10:00

Networking and Refreshment Break

Develop Effective Strategies for
Global HCP Interactions

10:30

I. Align Strategies for Global HCP Activities

II. Conduct Due Diligence and Validation Around Working Globally with HCPs

John Sheehan
HCP Transparency Reporting and Change Operations
Bristol-Myers Squibb

Sheea Sybblis
Counsel, US and Worldwide Regulatory
Bristol-Myers Squibb

12:00

Close of Conference

Want more agenda details? Download the brochure.

DAY ONE — WEDNESDAY, OCTOBER 11, 2017

7:30

Registration and Continental Breakfast

8:30

Chairman’s Welcome and Opening Remarks

Michael O’Connor
former Global Head, Compliance Operations
Alexion Pharmaceuticals

Identify an Effective Strategy for
Managing HCP Engagement

8:45

Establish a Comprehensive and Regulatory Framework to Successfully Manage All HCP Interactions

Richard Eschle
Executive Director, Corporate Ethics and Compliance
Eisai

9:30

Keys to Develop a Comprehensive and Upstream Approach to Compliance

Michaeline Daboul
President & CEO
MediSpend

10:15

Networking and Refreshment Break

10:45

THINK TANK Benchmark on How HCP Engagement Brings Value to an Organization

This session allows for open discussion within a roundtable format with the speaker facilitating collaboration with the audience.

Gina Barbarotto, MS, MBA
Director, Patient & Professional Relations
Purdue Pharma, L.P.

11:45

A Five Year Plan —
Building a Compliant Ecosystem Using Technology and Services

Shelley Harris
Director, Marketing Operations
Alkermes

Susan M. Hill
Senior Vice President, Global Products & Solutions
AHM

Martin L. Magazzolo
Senior Vice President, Global Sales & Marketing
AHM

12:30

Networking Luncheon

1:45

Maximizing the Effectiveness of Healthcare Provider Interactions

Kobi Gershoni
Co-Founder & Chief Research Officer
Signals Analytics

2:30

Best Practices for Open Payments Reporting of HCP Spend

Gus Papandrikos
Senior Director, Compliance
Daiichi Sankyo

3:15

Networking and Refreshment Break

3:45

Best Practices for Managing HCP Customer Expectations

Josh Yoder, PhD
Medical Science Liaison
Vertex Pharmaceuticals

Scott McConnell, PharmD
Senior Director, Medical Affairs
Alkermes, Inc.

4:30

THINK TANK Share Ideas for Compliant HCP Engagement

This session allows for open discussion within a roundtable format with the speaker facilitating collaboration with the audience.

Michael O’Connor
former Global Head, Compliance Operations
Alexion Pharmaceuticals

5:15

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO — THURSDAY, OCTOBER 12, 2017

7:45

Continental Breakfast

8:15

Chairman’s Review of Day One

Michael O’Connor
former Global Head, Compliance Operations
Alexion Pharmaceuticals

Capitalize on an External Communication Strategy for Efficient Management with HCPs

8:30

Assess Communication with HCPs on Speaker Programs and Ensure Correct Messaging

Howard Dorfman
Founder
H.L. Dorfman Pharmaceutical Consulting, LLC

9:15

PANEL Overcome Challenges in Contract Management to Streamline
HCP Operations

MODERATOR:

Gus Papandrikos
Senior Director, Compliance
Daiichi Sankyo

PANELISTS:

Sheea Sybblis
Counsel, US and Worldwide Regulatory
Bristol-Myers Squibb

Howard Dorfman
Founder
H.L. Dorfman Pharmaceutical Consulting, LLC

10:00

Networking and Refreshment Break

Develop Effective Strategies for
Global HCP Interactions

10:30

I. Align Strategies for Global HCP Activities

II. Conduct Due Diligence and Validation Around Working Globally with HCPs

John Sheehan
HCP Transparency Reporting and Change Operations
Bristol-Myers Squibb

Sheea Sybblis
Counsel, US and Worldwide Regulatory
Bristol-Myers Squibb

12:00

Close of Conference